| ASSET | YEAR | % RETURN |
|---|---|---|
Golden Matrix (GMGI) | 2016 | -99.99% |
BTCS (BTCS) | 2016 | -98.6% |
Avalon GloboCare (ALBT) | 2016 | -97.34% |
GT Biopharma (GTBP) | 2016 | -97.01% |
Predictive Oncology (POAI) | 2016 | -96.06% |
VerifyMe (VRME) | 2016 | -95.6% |
Nextplat (NXPL) | 2016 | -94.76% |
Worksport (WKSP) | 2016 | -93.64% |
Sellas Life Sciences (SLS) | 2016 | -93.36% |
Clean Energy Technologies, Inc Common Stock (CETY) | 2016 | -92.32% |
Aytu BioScience (AYTU) | 2016 | -91.02% |
Know Labs (KNW) | 2016 | -90.26% |
InspireMD (NSPR) | 2016 | -89.15% |
Armata Pharmaceuticals (ARMP) | 2016 | -88.94% |
Eledon Pharmaceuticals (ELDN) | 2016 | -88.56% |
JX Luxventure (JXG) | 2016 | -87.67% |
Protara Therapeutics (TARA) | 2016 | -87.33% |
Microbot Medical (MBOT) | 2016 | -86.55% |
Pulmatrix (PULM) | 2016 | -86.53% |
Kalvista Pharmaceuticals (KALV) | 2016 | -85.93% |
Bausch Health Companies (BHC) | 2016 | -85.19% |
Zevra Therapeutics (ZVRA) | 2016 | -85.04% |
NextTrip (NTRP) | 2016 | -84.86% |
Novavax (NVAX) | 2016 | -84.58% |
Imunon (IMNN) | 2016 | -84.25% |
